EW vs USB · P/E 47, rev $1.39B vs P/E 12, rev $28.66B
Edwards Lifesciences Corp (EW) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the EW and USB stock pages for the full models.
Not investment advice.